Current status of maintenance therapy in peptic ulcer disease. The ACG Committee on FDA-Related Matters
- PMID: 2897783
Current status of maintenance therapy in peptic ulcer disease. The ACG Committee on FDA-Related Matters
Similar articles
-
Sucralfate: worldwide experience in recurrence therapy.J Clin Gastroenterol. 1987;9 Suppl 1:18-22. J Clin Gastroenterol. 1987. PMID: 3302008 Review.
-
[Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].Wien Med Wochenschr. 1983;133(4-5):104-7. Wien Med Wochenschr. 1983. PMID: 6134397 Review. German. No abstract available.
-
[Peptic ulcer: current therapy].G Clin Med. 1987 Apr;68(4):197-209. G Clin Med. 1987. PMID: 2886387 Review. Italian. No abstract available.
-
Drug therapy for preventing peptic ulcer recurrence.Am Fam Physician. 1986 Nov;34(5):141-4. Am Fam Physician. 1986. PMID: 2877559
-
Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.Z Gastroenterol. 1987 Aug;25 Suppl 3:152-61. Z Gastroenterol. 1987. PMID: 3660894
Cited by
-
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer.Dig Dis Sci. 1994 Jul;39(7):1473-82. doi: 10.1007/BF02088051. Dig Dis Sci. 1994. PMID: 8026259 Clinical Trial.
-
Changes in surgical strategies for peptic ulcers before and after the introduction of H2-receptor antagonists and endoscopic hemostasis.Surg Today. 1995;25(4):318-23. doi: 10.1007/BF00311253. Surg Today. 1995. PMID: 7633122
-
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.Drug Saf. 1996 Jul;15(1):30-52. doi: 10.2165/00002018-199615010-00003. Drug Saf. 1996. PMID: 8862962 Review.
-
Effect of licorice versus bismuth on eradication of Helicobacter pylori in patients with peptic ulcer disease.Pharmacognosy Res. 2014 Oct;6(4):341-4. doi: 10.4103/0974-8490.138289. Pharmacognosy Res. 2014. PMID: 25276073 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical